Christoph Müller1, Judith Wendt1, Sabine Rauscher1, Raute Sunder-Plassmann2, Erika Richtig3, Ingrid Fae4, Gottfried Fischer4, Ichiro Okamoto1. 1. Department of Dermatology, Medical University of Vienna, Vienna, Austria. 2. Clinical Institute for Laboratory Medicine, Medical University of Vienna, Vienna, Austria. 3. Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria. 4. Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Abstract
Importance: Information on risk factors of subsequent melanomas would be helpful to identify patients at risk after the diagnosis of their first melanomas. Objective: To determine risk factors of subsequent melanomas. Design, Setting, and Participants: In this retrospective case-control study, 1648 participants with histologically verified cutaneous melanoma diagnosed from January 1, 1968, though March 16, 2015, were recruited from a tertiary referral center as part of the Molecular Markers of Melanoma study. CDKN2A was sequenced in 514 and MC1R in 953 participants. Data were analyzed from March 7, 2008, through March 25, 2015. Main Outcomes and Measures: Phenotypic traits and internal and external risk factors for the development of a second, third, or fourth melanoma. Results: In total, 1648 patients (53.6% men; mean [SD] age, 54 [15] years) were enrolled, including 1349 with single and 299 with multiple primary melanoma. Mean (SD) age at recruitment was 57 (15) years for the single-melanoma and 62 (14) years for the multiple-melanoma groups. From the internal risk factors, family history (odds ratio [OR], 1.76; 95% CI, 1.22-2.55; P = .006), CDKN2A high-risk mutations (OR, 4.03; 95% CI, 1.28-12.70; P = .02), and high numbers of nevi as a phenotypic risk factor (ORs, 2.23 [95% CI, 1.56-3.28, P < .001] for 20-30 smaller nevi and 2.56 [95% CI, 1.50-4.36; P = .003] for 20-30 larger nevi) were significantly associated with the risk of developing a subsequent primary melanoma using multivariate logistic regression analysis. Nonmelanoma skin cancer (OR, 2.57; 95% CI, 1.84-3.58; P < .001) and signs of actinic skin damage, particularly on the back (ORs, 1.91 [95% CI, 1.12-3.25; P = .04] for freckling and 1.92 [95% CI, 1.29-3.08; P = .007] for solar lentigines), additionally increased risk of a subsequent melanoma. All those factors were also associated with an earlier development of the second melanoma. Patients with 3 melanomas developed their second melanoma earlier than patients with only 2 melanomas (mean [SD] age, 55 [15] years for those with 2 primary melanomas; 52 [15] years for those with 3 primary melanomas). Time spent outdoors, solarium use, outdoor occupation, and hair color had no significant associations in these models. Conclusions and Relevance: According to the results of this study, internal factors (family history and genetic variants), number of nevi, and actinic damage on the back are more relevant for the development of subsequent melanomas than skin phototype or hair color. Patients with many nevi were younger at the time of the diagnosis of their first melanoma. This finding could help to identify persons at increased risk of developing multiple primary melanomas.
Importance: Information on risk factors of subsequent melanomas would be helpful to identify patients at risk after the diagnosis of their first melanomas. Objective: To determine risk factors of subsequent melanomas. Design, Setting, and Participants: In this retrospective case-control study, 1648 participants with histologically verified cutaneous melanoma diagnosed from January 1, 1968, though March 16, 2015, were recruited from a tertiary referral center as part of the Molecular Markers of Melanoma study. CDKN2A was sequenced in 514 and MC1R in 953 participants. Data were analyzed from March 7, 2008, through March 25, 2015. Main Outcomes and Measures: Phenotypic traits and internal and external risk factors for the development of a second, third, or fourth melanoma. Results: In total, 1648 patients (53.6% men; mean [SD] age, 54 [15] years) were enrolled, including 1349 with single and 299 with multiple primary melanoma. Mean (SD) age at recruitment was 57 (15) years for the single-melanoma and 62 (14) years for the multiple-melanoma groups. From the internal risk factors, family history (odds ratio [OR], 1.76; 95% CI, 1.22-2.55; P = .006), CDKN2A high-risk mutations (OR, 4.03; 95% CI, 1.28-12.70; P = .02), and high numbers of nevi as a phenotypic risk factor (ORs, 2.23 [95% CI, 1.56-3.28, P < .001] for 20-30 smaller nevi and 2.56 [95% CI, 1.50-4.36; P = .003] for 20-30 larger nevi) were significantly associated with the risk of developing a subsequent primary melanoma using multivariate logistic regression analysis. Nonmelanoma skin cancer (OR, 2.57; 95% CI, 1.84-3.58; P < .001) and signs of actinic skin damage, particularly on the back (ORs, 1.91 [95% CI, 1.12-3.25; P = .04] for freckling and 1.92 [95% CI, 1.29-3.08; P = .007] for solar lentigines), additionally increased risk of a subsequent melanoma. All those factors were also associated with an earlier development of the second melanoma. Patients with 3 melanomas developed their second melanoma earlier than patients with only 2 melanomas (mean [SD] age, 55 [15] years for those with 2 primary melanomas; 52 [15] years for those with 3 primary melanomas). Time spent outdoors, solarium use, outdoor occupation, and hair color had no significant associations in these models. Conclusions and Relevance: According to the results of this study, internal factors (family history and genetic variants), number of nevi, and actinic damage on the back are more relevant for the development of subsequent melanomas than skin phototype or hair color. Patients with many nevi were younger at the time of the diagnosis of their first melanoma. This finding could help to identify persons at increased risk of developing multiple primary melanomas.
Authors: Julia A Newton-Bishop; Yu-Mei Chang; Mark M Iles; John C Taylor; Bert Bakker; May Chan; Susan Leake; Birute Karpavicius; Sue Haynes; Elaine Fitzgibbon; Faye Elliott; Peter A Kanetsky; Mark Harland; Jennifer H Barrett; D Timothy Bishop Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-07-20 Impact factor: 4.254
Authors: Reinhard Dummer; Marco Siano; Robert E Hunger; Nicole Lindenblatt; Ralph Braun; Oliver Michielin; Daniela Mihic-Probst; Roger von Moos; Yousef Najafi; Merlin Guckenberger; Andreas Arnold Journal: Swiss Med Wkly Date: 2016-02-22 Impact factor: 2.193
Authors: J J Grob; J Gouvernet; D Aymar; A Mostaque; M H Romano; A M Collet; M C Noe; M P Diconstanzo; J J Bonerandi Journal: Cancer Date: 1990-07-15 Impact factor: 6.860
Authors: Joachim Hübner; Annika Waldmann; Nora Eisemann; Maria Noftz; Alan C Geller; Martin A Weinstock; Beate Volkmer; Rüdiger Greinert; Eckhard W Breitbart; Alexander Katalinic Journal: Eur J Cancer Prev Date: 2018-11 Impact factor: 2.497
Authors: Christopher K Bichakjian; Allan C Halpern; Timothy M Johnson; Antoinette Foote Hood; James M Grichnik; Susan M Swetter; Hensin Tsao; Victoria Holloway Barbosa; Tsu-Yi Chuang; Madeleine Duvic; Vincent C Ho; Arthur J Sober; Karl R Beutner; Reva Bhushan; Wendy Smith Begolka Journal: J Am Acad Dermatol Date: 2011-08-25 Impact factor: 11.527
Authors: C J Rowe; M H Law; J M Palmer; S MacGregor; N K Hayward; K Khosrotehrani Journal: J Eur Acad Dermatol Venereol Date: 2015-04-10 Impact factor: 6.166
Authors: M S Schuurman; A C de Waal; E J M Thijs; M M van Rossum; L A L M Kiemeney; K K H Aben Journal: Br J Dermatol Date: 2017-03-10 Impact factor: 9.302
Authors: A M Manganoni; C Farisoglio; G Tucci; F Facchetti; P G Calzavara Pinton Journal: J Eur Acad Dermatol Venereol Date: 2007-11 Impact factor: 6.166
Authors: Rodolfo David Palacios-Diaz; Blanca de Unamuno-Bustos; Carlos Abril-Pérez; Mónica Pozuelo-Ruiz; Javier Sánchez-Arraez; Ignacio Torres-Navarro; Rafael Botella-Estrada Journal: J Clin Med Date: 2022-04-22 Impact factor: 4.964
Authors: Alyssa A Wiener; Jessica R Schumacher; Jennifer M Racz; Sharon M Weber; Yaohui G Xu; Heather B Neuman Journal: Ann Surg Oncol Date: 2022-05-03 Impact factor: 4.339
Authors: A E Cust; C Badcock; J Smith; N E Thomas; L E Haydu; B K Armstrong; M H Law; J F Thompson; P A Kanetsky; C B Begg; Y Shi; A Kricker; I Orlow; A Sharma; S Yoo; S F Leong; M Berwick; D W Ollila; S Lo Journal: Br J Dermatol Date: 2019-11-27 Impact factor: 9.302
Authors: Catarina Campos; Sofia Fragoso; Rafael Luís; Filipe Pinto; Cheila Brito; Susana Esteves; Margarida Pataco; Sidónia Santos; Patrícia Machado; João B Vicente; Joaninha Costa Rosa; Branca M Cavaco; Cecília Moura; Marta Pojo Journal: Genes (Basel) Date: 2020-04-08 Impact factor: 4.096